drugset / Trial / NCT05499351
A Study of Booster Immunization With COVID-19 Vaccine,Inactivated Co -Administration With Influenza Vaccine and Pneumococcal Polysaccharide Vaccine
RandomizedParallel-groupOpen-labelPrevention
Summary
This study is a single center , randomized ,controlled and open-label phase Ⅳclinical trial of the booster immunization with the third dose of inactivated COVID-19 vaccine(CoronaVac)manufactured by Sinovac Research \& Development Co.,Ltd. The purpose of this study is to evaluate the immunogenicity and safety of the third dose of COVID-19 vaccine,inactivated (Vero Cell) co-administration with influenza vaccine and pneumococcal polysaccharide vaccine in healthy population aged 18 years and older.
Timeline
- Start
- 2021-10-15
- Primary completion
- 2021-12-05
- Completion
- 2022-05-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CoronaVac | Vaccine | 600 unknown | Other |
| Subject | Pneumovax 23 | Vaccine | 0.5 ml | Other |
| Subject | Quadrivalent influenza vaccine | Vaccine | 15 ug | Other |